supported by the Beijing Medical Award Foundation [YJHYXKYJJ-104]
Objective To assess the activities of biapenem against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis. Methods Biapenem/clavulanate(BP/CL) was evaluated for in vitro activity against Myc...
National Key New Drug R&D Program Foundation of China(Grant No.2009ZX09313-027).
An HPLC method for routine quality control of biapenem was established.A Dikma Diamonsil C_(18) column(250mm×4.6 mm,5μm) was used with diode array detection and single wavelength detection at 220 nm.The mobile phase...
Foundation item: National Key New Drag R&D Program Foundation of China (Grant No. 2009ZX09313-027).
An HPLC method for routine quality control of biapenem was established. A Dikma Diamonsil Cls column (250 mm× 4.6 mm, 5 μm) was used with diode array detection and single wavelength detection at 220 mm. The mobile...
National Natural Science Foundation of China (Grant No.30973597)
Biapenem, a new parenteral carbapenem, has been widely used for treating bacterial infections. A simple, effective and accurate method based on solid-phase extraction (SPE) and HPLC was developed for the quantitativ...
A simple high-performance liquid chromatography (HPLC) method was established and subsequently used to study the pharmacokinetics of biapenem in healthy volunteers. Chromatography separation was carried out using a ...